Wednesday, 2 December 2020

Protagonist's Hepcidin Mimetic Candidate PTG-300 Receives Fast Track Designation from the US Food and Drug Administration for Development in the Treatment of Polycythemia Vera - BioSpace

Protagonist's Hepcidin Mimetic Candidate PTG-300 Receives Fast Track Designation from the US Food and Drug Administration for Development in the Treatment of Polycythemia Vera  BioSpace

from "phlebotomist" - Google News https://bit.ly/3g4ekUL

No comments:

Post a Comment